Civic Intelligence

Path Drug Solutions

990 • Fiscal year 2013 • EIN 94-3384500

Jan 01, 2013 to Dec 31, 2013 • Filed on Nov 14, 2014

2201 Westlake Avenue No 20098121

(206) 285-3500

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

15th percentile

0.02x

Higher debt load relative to assets than 15% of similar nonprofits.

2013 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2013

Liabilities / Revenue

11th percentile

0.04x

Higher debt load relative to revenue than 11% of similar nonprofits.

2013 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2013

Net Margin

94th percentile

64%

Higher net margin than 94% of similar nonprofits.

2013 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2013

Top Officer Pay

83rd percentile

$522,867

Higher top officer pay than 83% of similar nonprofits.

Top officer pay equals 2.1% of source-year revenue.

2013 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2013

Asset Growth

95th percentile

48%

Faster asset growth than 95% of similar nonprofits.

2013 filings • 501(c)3 • $25M-$50M nonprofits • Annualized from 2012 to 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

Up

$42,859,417

Up $13,859,894 (+48%) from 2012

Net Assets

Up

$41,881,486

Up $15,765,930 (+60%) from 2012

Liabilities

Down

$977,931

Down $1,906,036 (-66%) from 2012

Revenue

$24,724,025

No earlier filing loaded for comparison.

Expenses

Down

$8,958,738

Down $2,693,132 (-23%) from 2012

Net Income

$15,765,287

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$60M$40M$20M$0Assets 2010: $26,215,343Liabilities 2010: $4,437,688Net Assets 2010: $21,777,6552010Assets 2011: $24,285,254Liabilities 2011: $1,581,867Net Assets 2011: $22,703,3872011Assets 2012: $28,999,523Liabilities 2012: $2,883,967Net Assets 2012: $26,115,5562012Assets 2013: $42,859,417Liabilities 2013: $977,931Net Assets 2013: $41,881,4862013Assets 2014: $37,978,413Liabilities 2014: $1,584,692Net Assets 2014: $36,393,7212014Assets 2015: $14,847,024Liabilities 2015: $1,605,303Net Assets 2015: $13,241,7212015Assets 2016: $10,229,897Liabilities 2016: $46,385Net Assets 2016: $10,183,5122016Assets 2017: $7,105,262Liabilities 2017: $708,783Net Assets 2017: $6,396,4792017Assets 2018: $0Liabilities 2018: $0Net Assets 2018: $02018

Highlighted filing

2013

Assets$42,859,417
Liabilities$977,931
Net Assets$41,881,486

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$30M$20M$10M$0-$10MExpenses 2010: $17,804,3432010Expenses 2011: $13,676,7372011Expenses 2012: $11,651,8702012Revenue 2013: $24,724,025Expenses 2013: $8,958,738Net Income 2013: $15,765,2872013Revenue 2014: $5,270,106Expenses 2014: $10,759,489Net Income 2014: -$5,489,3832014Revenue 2015: $7,139,715Expenses 2015: $5,997,711Net Income 2015: $1,142,0042015Revenue 2016: $216,478Expenses 2016: $3,275,717Net Income 2016: -$3,059,2392016Revenue 2017: $201,146Expenses 2017: $2,548,179Net Income 2017: -$2,347,0332017Revenue 2018: $2,972,163Expenses 2018: $3,576,203Net Income 2018: -$604,0402018

Highlighted filing

2013

Revenue$24,724,025
Expenses$8,958,738
Net Income$15,765,287
Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Signed
Nov 14, 2014
Return Version
2013v3.0
Gross Receipts
$24,747,241
Mission and Program Overview

Mission

Path drug solutions (pds) develops and advances safe and effective medicines for the prevention and treatment of diseases disproportionately affecting women and children in low-resource settings. We work with a variety of public- and private-sector stakeholders to build cross-sector collaborations, secure intellectual property, revisit promising drugs or drug candidates that have been set aside for nonmedical reasons (e.g., lack of earning potential), and harness scientific and manufacturing capacity in high- and low- or middle-income countries to ensure drugs are available, accessible, and affordable to all those who need them.

SEE PART III, LINE 1.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$21,622,683$28,480,673▲ $6,857,990
Pledges and Grants Receivable$6,799,174$13,545,716▲ $6,746,542
Cash and Non-Interest-Bearing Accounts$277,683$763,123▲ $485,440
Prepaid Expenses and Deferred Charges$138,279$35,758▼ $102,521
Land, Buildings, and Equipment, Net$97,806$31,160▼ $66,646
Investments in Publicly Traded Securities$1,644$2,286▲ $642
Accounts Receivable$62,254$701▼ $61,553
Total Assets$28,999,523$42,859,417▲ $13,859,894
Liabilities
Accounts Payable and Accrued Expenses$2,883,967$977,931▼ $1,906,036
Total Liabilities$2,883,967$977,931▼ $1,906,036
Net Assets / Fund Balance
Temporarily Rstr Net Assets$25,495,072$40,815,973▲ $15,320,901
Unrestricted Net Assets$620,484$1,065,513▲ $445,029
Total Net Assets Fund Balance$26,115,556$41,881,486▲ $15,765,930
Total Liabilities and Net Assets / Fund Balance$28,999,523$42,859,417▲ $13,859,894

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$26,419$52,840$79,259
Leasehold Improvements$4,741$3,844$8,585
Compensation and Service Providers

Employees

NameTitleOtherTotal
Olivia PoliusTreasurer & CFO (began 8/23/13)$105,627$105,627

Board Members and Trustees

NameTitle
Steven B DavisPresident & CEO
Jorge FloresDirector
Ken DuncanDirector
David KaslowDirector (began 10/2/13)
Keith ChirgwinDirector (began 11/18/13)
Jacqueline SherrisDirector (until 10/28/13)
Tom BrewerDirector (until 11/18/13)
Daniel LasterSecretary
Eric G WalkerTreasurer & CFO (until 8/23/13)
Revenue and Support

Revenue Composition

Contributions and Grants
$24,735,210
Program Service Revenue
$0
Investment Income
$-11,280
Other Revenue
$95
All Other Contributions
$24,199,721
Change in Net Assets
$15,765,287
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$5,369,107
Other Expenses$3,589,631
Total Fundraising Expense$12,937
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$4,860,772--$4,860,772
Royalties$727,728--$727,728
Foreign Grants$508,335--$508,335
Travel$503,965$1,260-$505,225
Fees for Services Other$326,096$3,123-$329,219
Occupancy$255$204,110-$204,365
Conferences and Meetings$109,559$223-$109,782
Fees for Services Legal$100,660$4,290-$104,950
Office Expenses$49,980$42,831$532$93,343
Other Expenses$30,098$8,998-$30,098
All Other Expenses$3,979$9,732$12,300$26,011
Depreciation Depletion-$17,010-$17,010
Information Technology$3,362$8,128$105$11,595
Insurance$3,434$1,676-$5,110
Advertising$1,739--$1,739
Fees for Services Accounting$1,609--$1,609
Total Functional Expenses$8,644,420$301,381$12,937$8,958,738
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
91-1157127-501(c)(3)General Support$4,022,391
43-0654872-501(c)(3)Product Development$838,371

International Summary

Offices
0
Employees
0
Spending
$2,417,962

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
EuropeProgram ServicesProduct Development00$903,085
South AsiaProgram Services-00$616,017
South AsiaGrantmaking-00$501,665
South AsiaProgram Services-00$268,433
EuropeProgram ServicesInternational Development00$41,384
East Asia and the PacificProgram ServicesProduct Development00$30,840
South AsiaManagement & GeneralInternational Development00$27,361
North AmericaProgram ServicesProduct Development00$21,015
EuropeGrantmakingInternational Development00$6,670
Middle East and North AfricaProgram ServicesProduct Development00$1,492
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11

The form 990 was prepared by an outside accounting firm using information provided by path accounting services staff. Path senior management reviewed the draft form. A copy of the final 990 was sent to path's board of directors for comment. After the comment period, the cfo signed the return.

Form 990, Part VI, Section B, Line 12C

Pds has a written conflict of interest policy under which all pds board members and officers must complete a conflict of interest disclosure form each year. Pds does not have employees. Pds is a supporting organization to path within the meaning of irc section 509(a)(3), and pds contracts with path for management services. Path has a written conflict of interest policy under which all path board members, officers, and staff above a designated level must complete a conflict of interest disclosure form each year. All pds and path disclosure forms are reviewed and kept on file. A conflict management plan is developed for any employee with a significant actual or perceived conflict of interest.

Form 990, Part VI, Section C, Line 19

Pds makes its governing documents, conflict of interest policy, and financial statements available to the public upon request.

Filing and Contact Details

Filer

EIN
94-3384500
Phone
2062853500

Signing Officer

Name
Olivia Polius
Title
CFO
Phone
2062853500
Signed
2014-11-14
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Olivia Polius
Formed
2000
Legal Domicile
CA
Voting Board Members
7
Independent Board Members
3
Employees
0
Volunteers
0

Preparer

Phone
3019519090
Raw XML AppendixShowing 400 of 722 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02883967
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0977931
IRS990/AccountsReceivableGrp/BOYAmt062254
IRS990/AccountsReceivableGrp/EOYAmt0701
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SEE PART III, LINE 1.
IRS990/AdvertisingGrp/ProgramServicesAmt01739
IRS990/AdvertisingGrp/TotalAmt01739
IRS990/AllOtherContributionsAmt024199721
IRS990/AllOtherExpensesGrp/FundraisingAmt012300
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt09732
IRS990/AllOtherExpensesGrp/ProgramServicesAmt03979
IRS990/AllOtherExpensesGrp/TotalAmt026011
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine10OLIVIA POLIUS CHIEF FINANCIAL OFFICER
IRS990/BooksInCareOfDetail/PhoneNum02062853500
IRS990/BooksInCareOfDetail/USAddress/AddressLine102201 WESTLAKE AVENUE SUITE 200
IRS990/BooksInCareOfDetail/USAddress/City0SEATTLE
IRS990/BooksInCareOfDetail/USAddress/State0WA
IRS990/BooksInCareOfDetail/USAddress/ZIPCode098121
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0277683
IRS990/CashNonInterestBearingGrp/EOYAmt0763123
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt0223
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0109559
IRS990/ConferencesMeetingsGrp/TotalAmt0109782
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt024735210
IRS990/CYGrantsAndSimilarPaidAmt05369107
IRS990/CYInvestmentIncomeAmt0-11280
IRS990/CYOtherExpensesAmt03589631
IRS990/CYOtherRevenueAmt095
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt015765287
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt08958738
IRS990/CYTotalFundraisingExpenseAmt012937
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt024724025
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt017010
IRS990/DepreciationDepletionGrp/TotalAmt017010
IRS990/Desc0ALTHOUGH MANY POOR COUNTRIES NEED NEW, MORE EFFECTIVE, AND LOWER-COST MEDICINES TO MEET CRITICAL HEALTH CHALLENGES (INCLUDING DIARRHEA, MALARIA, AND HIV), RESEARCH AND DEVELOPMENT FOR THESE DRUGS MAY NOT BE A PRIORITY FOR COMMERCIAL PHARMACEUTICAL GROUPS. PDS OVERCOMES THIS BARRIER BY CREATING CROSS-SECTOR COLLABORATIONS, OPENING DOORS FOR THE SHARING AND DONATION OF INTELLECTUAL PROPERTY, AND HARNESSING THE SCIENTIFIC AND MANUFACTURING CAPACITY OF BOTH DEVELOPED AND DEVELOPING COUNTRIES. WE ASSEMBLE EXPERIENCED AND DEDICATED TEAMS; IDENTIFY PROMISING DRUG CANDIDATES; TRANSLATE THESE CANDIDATES INTO SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES; AND COLLABORATE WITH COMPANIES TO MANUFACTURE AND DISTRIBUTE NEWLY APPROVED THERAPIES TO THOSE WHO NEED THEM MOST.IN 2013, THE TEAM ADVANCED MEDICINES AND RESEARCH TO COMBAT TOP THREATS TO WOMEN AND CHILDREN WORLDWIDE. OUR CROSS-SECTOR PARTNERSHIPS CONTINUED TO MODEL BEST PRACTICES IN INNOVATIVE COLLABORATION TO ACHIEVE SHARED PUBLIC HEALTH GOALS. THIS YEAR, THE COMMERCIAL LAUNCH OF A SEMISYNTHETIC VERSION OF ARTEMISININ, THE KEY INGREDIENT IN GOLD-STANDARD ANTIMALARIAL TREATMENTS, MARKED THE CULMINATION OF EFFORTS BEGUN A DECADE AGO.FOR YEARS, THE VOLATILE COST AND FLUCTUATING SUPPLY OF PLANT-DERIVED ARTEMISININ CHALLENGED THE GLOBAL MARKET WITH UNPREDICTABLE AVAILABILITY AND PRICING. PDS WORKED WITH PARTNERS TO DEVELOP A STABLE, AFFORDABLE, SEMISYNTHETIC SOURCE TO SUPPLEMENT THE BOTANICAL SUPPLY. OUR UNIQUE APPROACH BRIDGED THE GAP BETWEEN SMART CONCEPT AND REAL-WORLD IMPACT, BRINGING THE PRODUCT FROM SMALL LABORATORY BATCHES, THROUGH INDUSTRIAL MANUFACTURE, AND ON TO INTRODUCTION. THIS YEAR, OUR FRENCH MANUFACTURING PARTNER, SANOFI, LAUNCHED COMMERCIAL PRODUCTION OF SEMISYNTHETIC ARTEMISININ (SSART), MAKING IT AVAILABLE TO PREQUALIFIED MANUFACTURERS.ALSO THIS YEAR, THE WORLD HEALTH ORGANIZATION ANNOUNCED THAT SSART IS ACCEPTABLE FOR USE IN THE MANUFACTURE OF ARTEMISININ-BASED MEDICINES, MAKING IT EASIER FOR PREQUALIFIED MANUFACTURERS TO BEGIN USING THE INGREDIENT IN THEIR PRODUCTS. A CONSISTENT SUPPLY OF SSART CAN AID IN STABILIZING THE GLOBAL MARKET FOR ARTEMISININ AND, ULTIMATELY, HELP ENSURE THAT LIFESAVING ANTIMALARIAL DRUGS ARE RELIABLY AVAILABLE TO MILLIONS OF PEOPLE. OUR SUCCESS DEMONSTRATES THE POWER OF BROAD COLLABORATION BETWEEN INDUSTRY, SCIENTIFIC, NONPROFIT, AND ACADEMIC PARTNERS TO ACHIEVE SHARED HUMANITARIAN GOALS. IN 2013, PDS ALSO CONTINUED RESEARCH TRIALS TO ADVANCE EFFECTIVE AND AFFORDABLE DRUGS TO TREAT DIARRHEAL DISEASE, ONE OF THE LEADING CAUSES OF DEATH AMONG CHILDREN UNDER FIVE. ALTHOUGH DIARRHEA CAN BE TREATED, EXISTING TOOLS DO NOT ALWAYS REACH PEOPLE WHO NEED THEM. SOMETIMES THIS IS BECAUSE EFFECTIVE TREATMENTS, ALTHOUGH LIFESAVING, DO NOT EASE SYMPTOMS, WHICH CAN DISCOURAGE USE AND ADHERENCE. TO HELP OVERCOME THIS BARRIER, WE ARE DEVELOPING A NEW ANTISECRETORY DRUG CANDIDATE (IOWH032) THAT HAS THE POTENTIAL TO SHORTEN THE DURATION AND SEVERITY OF DIARRHEA SYMPTOMS. FOLLOWING PHASE 1 RESEARCH DEMONSTRATING THAT THE CANDIDATE IS SAFE, WELL-TOLERATED, AND CAUSES NO SERIOUS ADVERSE EVENTS, WE COMPLETED ANOTHER TWO-PART STUDY THIS YEAR AMONG HEALTHY ADULT MALE AND FEMALE VOLUNTEERS, AND ADULT MALES WITH CHOLERA, IN BANGLADESH. BY PROVIDING FASTER RELIEF OF DIARRHEA SYMPTOMS, ANTISECRETORY DRUGS LIKE IOWH032 MAY COMPLEMENT AND ENCOURAGE WIDER ADOPTION OF ORAL REHYDRATION SOLUTION (ORS) AND OTHER PROVEN TREATMENTS. IN ADDITION, WE LAUNCHED A PHASE 2 RANKING TRIAL IN BANGLADESH TO COMPARE AND EVALUATE THREE NEW FORMULATIONS OF ORS, A PROVEN TREATMENT FOR DIARRHEAL DISEASE THAT STILL DOES NOT REACH ENOUGH PEOPLE. IT IS ANTICIPATED THAT THE NEW FORMULATION WILL PROVIDE THE SAME EFFECTIVENESS IN TREATING OR PREVENTING DEHYDRATION AS CONVENTIONAL ORS BUT WITH THE ADDED BENEFIT OF REDUCING THE DURATION OF ILLNESS. WE WILL USE THE TRIAL TO SELECT THE FORMULATION TO ADVANCE TO FURTHER CLINICAL STUDIES.FINALLY, PDS IS DEVELOPING NEW TOOLS TO COMBAT HIV AND AIDS, WHICH CONTIN
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt08644420
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt01609
IRS990/FeesForServicesAccountingGrp/TotalAmt01609
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt04290
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0100660
IRS990/FeesForServicesLegalGrp/TotalAmt0104950
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt03123
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0326096
IRS990/FeesForServicesOtherGrp/TotalAmt0329219
IRS990/ForeignActivitiesInd01
IRS990/ForeignCountryCd0IN
IRS990/ForeignFinancialAccountInd01
IRS990/ForeignGrantsGrp/ProgramServicesAmt0508335
IRS990/ForeignGrantsGrp/TotalAmt0508335
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt039.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt139.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt239.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt339.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt438.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt70.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt80.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt938.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt42.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt52.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt62.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt72.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt82.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt92.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt041628
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt16116
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt234611
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt335498
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt427440
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt939519
IRS990/Form990PartVIISectionAGrp/PersonNm0STEVEN B DAVIS
IRS990/Form990PartVIISectionAGrp/PersonNm1OLIVIA POLIUS
IRS990/Form990PartVIISectionAGrp/PersonNm2ERIC G WALKER
IRS990/Form990PartVIISectionAGrp/PersonNm3DANIEL LASTER
IRS990/Form990PartVIISectionAGrp/PersonNm4JACQUELINE SHERRIS
IRS990/Form990PartVIISectionAGrp/PersonNm5TOM BREWER
IRS990/Form990PartVIISectionAGrp/PersonNm6KEITH CHIRGWIN
IRS990/Form990PartVIISectionAGrp/PersonNm7KEN DUNCAN
IRS990/Form990PartVIISectionAGrp/PersonNm8JORGE FLORES
IRS990/Form990PartVIISectionAGrp/PersonNm9DAVID KASLOW
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt0481239
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt199511
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt2352054
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt3225160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt4208881
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt9322463
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT & CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt1TREASURER & CFO (BEGAN 8/23/13)
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER & CFO (UNTIL 8/23/13)
IRS990/Form990PartVIISectionAGrp/TitleTxt3SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR (UNTIL 10/28/13)
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR (UNTIL 11/18/13)
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR (BEGAN 11/18/13)
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR (BEGAN 10/2/13)
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02000
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/OtherAmt0-23216
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt05369107
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt04860772
IRS990/GrantsToDomesticOrgsGrp/TotalAmt04860772
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt024747241
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt03
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt0105
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt08128
IRS990/InformationTechnologyGrp/ProgramServicesAmt03362
IRS990/InformationTechnologyGrp/TotalAmt011595
IRS990/InsuranceGrp/ManagementAndGeneralAmt01676
IRS990/InsuranceGrp/ProgramServicesAmt03434
IRS990/InsuranceGrp/TotalAmt05110
IRS990/InvestmentIncomeGrp/ExclusionAmt011936
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt011936
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt01644
IRS990/InvestmentsPubTradedSecGrp/EOYAmt02286
IRS990/IRPDocumentCnt012
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt056684
IRS990/LandBldgEquipBasisNetGrp/BOYAmt097806
IRS990/LandBldgEquipBasisNetGrp/EOYAmt031160
IRS990/LandBldgEquipCostOrOtherBssAmt087844
IRS990/LegalDomicileStateCd0CA
IRS990/LessCostOthBasisSalesExpnssGrp/OtherAmt023216
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0PATH DRUG SOLUTIONS (PDS) WORKS TO DEVELOP SAFE AND EFFECTIVE NEW MEDICINES FOR DISEASES THAT DISPROPORTIONATELY AFFECT PEOPLE IN DEVELOPING COUNTRIES AND ENSURE THAT THEY ARE AVAILABLE AND ACCESSIBLE WHERE THEY ARE NEEDED MOST.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt026115556
IRS990/NetAssetsOrFundBalancesEOYAmt041881486
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-23216
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-23216
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0643
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0204110
IRS990/OccupancyGrp/ProgramServicesAmt0255
IRS990/OccupancyGrp/TotalAmt0204365
IRS990/OfficeExpensesGrp/FundraisingAmt0532
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt042831
IRS990/OfficeExpensesGrp/ProgramServicesAmt049980
IRS990/OfficeExpensesGrp/TotalAmt093343
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0SUBCONTRACTS
IRS990/OtherExpensesGrp/Desc1EQUIPMENT R&M / PROC.
IRS990/OtherExpensesGrp/Desc2LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc3CURRENCY FLUCTUATION
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt08998
IRS990/OtherExpensesGrp/ProgramServicesAmt01174694
IRS990/OtherExpensesGrp/ProgramServicesAmt1148757
IRS990/OtherExpensesGrp/ProgramServicesAmt289398
IRS990/OtherExpensesGrp/ProgramServicesAmt330098
IRS990/OtherExpensesGrp/TotalAmt01174694
IRS990/OtherExpensesGrp/TotalAmt1157755
IRS990/OtherExpensesGrp/TotalAmt289398
IRS990/OtherExpensesGrp/TotalAmt330098
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0OTHER REIMBURSEMENTS
IRS990/OtherRevenueMiscGrp/ExclusionAmt095
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt095
IRS990/OtherRevenueTotalAmt095
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt06799174
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt013545716
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0138279
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt035758
IRS990/PrincipalOfficerNm0OLIVIA POLIUS
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02365799
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt05066914
IRS990/PYInvestmentIncomeAmt072342
IRS990/PYOtherExpensesAmt04732178
IRS990/PYOtherRevenueAmt014983
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-9198746
IRS990/PYSalariesCompEmpBnftPaidAmt01852778
IRS990/PYTotalExpensesAmt011651870
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02453124
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt015765287
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt0535489
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RoyaltiesGrp/ProgramServicesAmt0727728
IRS990/RoyaltiesGrp/TotalAmt0727728
IRS990/SavingsAndTempCashInvstGrp/BOYAmt021622683
IRS990/SavingsAndTempCashInvstGrp/EOYAmt028480673
IRS990ScheduleA/CertificationInd0X
IRS990ScheduleA/Contribution35ControlledInd00
IRS990ScheduleA/ContributionControllerInd00
IRS990ScheduleA/ContributionFamilyInd00
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0911157127
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeDesc07
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt08958738
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine10PATH
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt08958738
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/EquipmentGrp/BookValueAmt026419
IRS990ScheduleD/EquipmentGrp/DepreciationAmt052840
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt079259
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt04741
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt03844
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt08585
IRS990ScheduleD/TotalBookValueLandBuildingsAmt031160
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt80
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt90
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt80
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt90
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt030840
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt1903085
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt241384
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt36670
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt41492
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt521015
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt627361
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt7268433
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt8616017
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt9501665
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EAST ASIA AND THE PACIFIC
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt2EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt3EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt4MIDDLE EAST AND NORTH AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt5NORTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt6SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt7SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt8SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt9SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt0PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt1PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt2INTERNATIONAL DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt3INTERNATIONAL DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt4PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt5PRODUCT DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt6INTERNATIONAL DEVELOPMENT
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt2PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt3GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt4PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt5PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt6MANAGEMENT & GENERAL
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt7PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt8PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt9GRANTMAKING
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt01117682
IRS990ScheduleF/ContinutationTotalEmployeeCnt00
IRS990ScheduleF/ContinutationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt06670
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt1252123
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt233790
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt335897
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt417221

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings